Skip to main content

Cardio Diagnostics Holdings, Inc.

CDIO
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0001870144

No open-market purchases or sales by Cardio Diagnostics Holdings, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $422.7K in total; no superinvestor holds it.

Other share classesCDIOW

Q2 2025 vs. Q1 2025

How the institutions holding Cardio Diagnostics Holdings, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of CDIO: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders2316−7
SharesConverted for a 1-for-30 split84.6K84.8K+273.53 (+0.3%)
Value$836.3K$305.0K−$531.3K (−63.5%)

New holders (4)

Institutions that held Cardio Diagnostics Holdings, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to CDIO in Q2 2025
InstitutionSharesValue% of portfolio
Susquehanna International Group, LLP13,060$47.0K0.00%
Royal Bank of Canada7,500$27.0K0.00%
SRS Capital Advisors, Inc.6$220.00%
FMR LLC3$110.00%

Sold out (11)

Institutions that held Cardio Diagnostics Holdings, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of CDIO in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Jane Street Group, LLC80,834$26.7K
State Street Corp62,600$20.7K
XTX Topco Ltd57,372$18.9K
Mariner, LLC50,000$16.5K
Northern Trust Corp48,619$16.0K
HRT Financial LP44,649$14.0K
Two Sigma Securities, LLC42,232$13.9K
Integrated Wealth Concepts LLC40,000$13.2K
LPL Financial LLC15,199$5.02K
Endowment Wealth Management, Inc.14,307$4.72K
JPMorgan Chase & Co1,500$495